Mission of the CBT

The Center for Biomolecular Therapeutics (CBT) is comprised of and serves faculty from the University of Maryland, Baltimore (including the Schools of Medicine & Pharmacy), the University of Maryland College Park, the University of Maryland, Baltimore County, the Institute of Bioscience and Biotechnology Research, and several other Universities within the USM. The goal of the CBT is to do state-of-the-art nationally funded research with a team science approach that focuses on basic science leading to therapeutic development. Toward this goal, important biomolecules and biological pathways are considered to aggressively target with chemical or biological molecules, and these reagents are developed further, so they can be tested in the clinic. 

Keys to CBT’s Success:

1. Promote a top-quality entrepreneurial scientific environment and contribute to the development of diagnostics and therapeutics.
2. Collaborate with research and clinical faculty across all USM campuses to identify important biological targets.
3. Enhance the educational expertise across USM surrounding the discovery-to-commercialization “pipeline”, including regulatory and business expertise, by creating a program of visiting faculty scientists and postdoctoral fellows.
4. Interact with the biotechnology and pharmaceutical industries to help maintain CBT’s focus on the most biomedically and commercially important targets, diagnostics, and therapeutics.